Document is current

Article History

Received: 15 December 2020

Accepted: 7 April 2021

First Online: 23 April 2021

Declarations

:

: The PREDICT study (under which this research was conducted) was approved by the New Zealand Northern Region Ethics Committee Y in 2003 (AKY/03/12/314), with subsequent annual approval by the New Zealand National Multi Region Ethics Committee since 2007 (MEC07/19/EXP). Participant informed consent was not obtained, consistent with a waiver granted by the ethics committee, because the study involved secondary use of patient data that was anonymized prior to being received by the research team.

: Not applicable.

: This research was funded by a Project Grant (15/165) from the Health Research Council of New Zealand (HRC). CG, MH, RJ, AK, SM, KP and SW are receiving funding from the HRC for programme, project and Clinical Research Training grants for CVD research. KP is the recipient of a Heart Foundation of New Zealand Hynds Senior Fellowship and CG was the recipient of a National Heart Foundation of New Zealand Research Fellowship. SW was the recipient of a Fellowship in Health Innovation and Quality Improvement, funded by the Stevenson Foundation. Outside of this research, SW and KP have received funding from the Heart Foundation of New Zealand (Project Grant for quality improvement and structural heart disease, respectively) and SW from Roche Diagnostics Ltd (Project Grant for point of care testing trial).